Acquisition (code A) of 30,000 shares at $0 per share.
Reporting Person Levin Michaela · Officer Title Chief Business Officer · Transaction Code A
Traded Aug 31, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0000905148-26-004065 · filed 2026-09-02 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Acrivon Therapeutics, Inc. (ACRV)." Disclosed 2026-09-02. https://desqlong.com/cards/0000905148-26-004065-1 (retrieved 2026-09-26).